Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$24.75 - $39.14 $648,821 - $1.03 Million
-26,215 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$16.3 - $30.64 $629,131 - $1.18 Million
-38,597 Reduced 59.55%
26,215 $803,000
Q2 2020

Aug 12, 2020

SELL
$7.95 - $18.81 $85,693 - $202,752
-10,779 Reduced 14.26%
64,812 $1.06 Million
Q1 2020

May 14, 2020

SELL
$6.45 - $14.04 $11,809 - $25,707
-1,831 Reduced 2.36%
75,591 $748,000
Q4 2019

Feb 14, 2020

SELL
$12.97 - $15.94 $112,385 - $138,120
-8,665 Reduced 10.07%
77,422 $1.06 Million
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $33,807 - $47,834
-2,292 Reduced 2.59%
86,087 $1.31 Million
Q2 2019

Aug 01, 2019

SELL
$14.71 - $19.79 $3,530 - $4,749
-240 Reduced 0.27%
88,379 $1.74 Million
Q3 2018

Nov 13, 2018

SELL
$16.65 - $21.85 $239,759 - $314,640
-14,400 Reduced 13.98%
88,619 $1.55 Million
Q2 2018

Aug 01, 2018

SELL
$14.8 - $18.8 $29 - $37
-2 Reduced -0.0%
103,019 $1.88 Million
Q1 2018

May 10, 2018

SELL
$14.5 - $23.4 $984,550 - $1.59 Million
-67,900 Reduced 39.73%
103,021 $1.93 Million
Q4 2017

Feb 01, 2018

SELL
$13.5 - $16.65 $773,550 - $954,044
-57,300 Reduced 25.11%
170,921 $2.61 Million
Q3 2017

Nov 14, 2017

BUY
$6.05 - $14.95 $1.38 Million - $3.41 Million
228,221
228,221 $3.4 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $490M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Minerva Advisors LLC Portfolio

Follow Minerva Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Minerva Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Minerva Advisors LLC with notifications on news.